Restless legs syndrome

References

• Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol. 2005;4:465–475.
   PubMed Web of Science ®Google Scholar
• Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med. 2003;4:101–119.
   PubMed Web of Science ®Google Scholar
• American Sleep Disorders Association, Diagnostic Classification Steering Committee. International Classification of Sleep Disorders. Diagnostic and Coding Manual. 2nd ed. Westchester: American Academy of Sleep Medicine; 2005.
   Google Scholar
• Zucconi M, Manconi M. Sleep disturbances in restless leg syndrome (RLS) and periodic limb movements(PLM). In: Pandi-Perumal SR, Monti JM, editors. Clinical Pharmacology of Sleep. Basel: Birkhâuser Verlag; 2006:61–79.
   Google Scholar
• Lugaresi E, Tassinari CA, Coccagna G, Ambrosetto C. Particularités cliniques et polygraphiques du syndrome d’impatience des membres inférieurs. (Clinical and polygraphic syndrome in lower limbs). Rev Neurol (Paris). 1965;113:545–555. (French).
   Google Scholar
• Coleman RM. . Periodic movements in sleep (nocturnal myoclonus). In: Guilleminault C, editor. Sleeping and Waking Disorders: Indications and Techniques. Menlo Park: Addison Wesley; 1982.
   Google Scholar
• Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12:61–65.
   PubMed Web of Science ®Google Scholar
• Montplaisir J, Boucher S, Nicolas A, et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Mov Disord. 1998;13:324–329.
   PubMed Web of Science ®Google Scholar
• Ekbom K, Ulfberg J. Restless legs syndrome. J Intern Med. 2009;266:419–431.
   PubMed Web of Science ®Google Scholar
• Blom S, Ekbom KA. Comparison between akathisia developing on treatment with phenothiazine derivatives and the restless legs syndrome. Acta Med Scand. 1961;170:689–694.
   Google Scholar
• Willis T. The London Practice of Physick. London: Thomas Basset and William Crook; 1685.
   Google Scholar
• Ekbom K, Ekbom KA. An early Swedish description of restless legs (Huss 1849). Lakartidningen. 1974;71:2905–2906. Swedish.
   Google Scholar
• Konofal E, Karroum E, Montplaisir J, Derenne JP, Arnulf I. Two early descriptions of restless syndrome and periodic leg movements by Boissier de Sauvages (1763) and Gilles de la Tourette (1898). Sleep Med. 2009;10:586–591.
   PubMed Web of Science ®Google Scholar
• Ekbom KA. Restless legs. Acta Med Scand. 1945;158:1–123.
   Google Scholar
• Ekbom KA. Restless legs syndrome. Neurology. 1960;10:868–873.
   PubMed Web of Science ®Google Scholar
• Hening W, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5:237–246.
   PubMed Web of Science ®Google Scholar
• Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology. 2000;54:1064–1068.
   PubMed Web of Science ®Google Scholar
• Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164:196–202.
   PubMed Web of Science ®Google Scholar
• Ulfberg J, Nyström B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord. 2001;16:1159–1163.
   PubMed Web of Science ®Google Scholar
• Ulfberg J, Nyström B, Carter N, Edling C. Restless legs syndrome among working-aged women. Eur Neurol. 2001;46:17–19.
   PubMed Web of Science ®Google Scholar
• Bjorvatn B, Leissner L, Ulfberg J, et al. Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med. 2005;6:307–312.
   PubMed Web of Science ®Google Scholar
• Cho SJ, Hong JP, Hahm BJ, et al. Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders. Sleep. 2009;32:1069–1076.
   PubMed Web of Science ®Google Scholar
• Sevim S, Dogu O, Camdeviren H, et al. Unexpected low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology. 2003;61:1562–1569.
   PubMed Web of Science ®Google Scholar
• Winkelmann J, Schadrack J, Wetter TC, Zieglgansberger W, Trenkwalder C. Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients. Sleep Med. 2001;2: 57–61.
   PubMed Web of Science ®Google Scholar
• Wetter TC, Stiasny K, Winkelmann J, et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology. 1999;52:944–950.
   PubMed Web of Science ®Google Scholar
• Bucher SF, Seelos KC, Oertel WH, Reiser M, Trenkwalder C. Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol. 1997;41:639–645.
   PubMed Web of Science ®Google Scholar
• Lugaresi E, Cirignotta F, Coccagna G, Montagna P. Nocturnal myoclonus and restless legs syndrome. In: Fahn S, Marsden CD, Van Woert MH, editors. Myoclonus. New York: Raven Press; 1986.
   Google Scholar
• Trenkwalder C, Bucher SF, Oertel WH, Proeckl D, Plendl H, Paulus W Bereitschafts potential in idiopathic and symptomatic restless legs syndrome. Electroencephalogr Clin Neurophysiol. 1993;89:95–103.
   PubMedGoogle Scholar
• Bara-Jimenez W, Aksu M, Graham B, Sato S, Hallett M. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology. 2000;54:1609–1615.
   PubMed Web of Science ®Google Scholar
• Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol. 2001;18:128–147.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Paulus W. Why do restless legs occur at rest? Pathophysiology of neuronal structures in RLS. Neurophysiology of RLS (part 2). Clin Neurophysiol. 2004;115:1975–1988.
   PubMed Web of Science ®Google Scholar
• Brodeur C, Montplaisir J, Godbout R, Marinier R. Treatment of restless legs syndrome and periodic movements during sleep with L dopa: a double-blind, controlled study. Neurology. 1988;38:1845–1848.
   PubMed Web of Science ®Google Scholar
• Von Scheele C. Levodopa in restless legs. Lancet. 1986;2:426–427.
   Google Scholar
• Trenkwalder C, Stiasny K, Pollmacher T, et al. L-Dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep. 1995;18:681–688.
   PubMed Web of Science ®Google Scholar
• Earley CJ, Yaffee JB, Allen RP. Randomized, double-blind, placebo controlled trial of pergolide in restless legs syndrome. Neurology. 1998;51:1599–1602.
   PubMed Web of Science ®Google Scholar
• Wetter TC, Stiasny K, Winkelmann J. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology. 1999;52:944–950.
   PubMed Web of Science ®Google Scholar
• Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology. 1999;52:938–943.
   PubMed Web of Science ®Google Scholar
• Freeman A, Rye D, Bliwise DL, et al. Ropinirole for restless legs syndrome (RLS): an open-label and double-blind placebo-controlled study. Neurology. 2001;56:A5.
   Web of Science ®Google Scholar
• Walters AS, Wagner ML, Hening WA, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep. 1993;16:327–332.
   PubMed Web of Science ®Google Scholar
• Garcia-Borreguero D, Larrosa O, De la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology. 2002;59:1573–1579.
   PubMed Web of Science ®Google Scholar
• Winkelmann J, Schadrack J, Wetter TC, et al. Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients. Sleep Med. 2001;2:57–61.
   PubMed Web of Science ®Google Scholar
• Winkelman JW. Considering the causes of RLS. Eur J Neurol. 2006;13:8–14.
   PubMed Web of Science ®Google Scholar
• Staedt J, Stoppe G, Kogler A, et al. Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration. Eur Arch Psychiatry Clin Neurosci. 1995;245:8–10.
   PubMed Web of Science ®Google Scholar
• Staedt J, Stoppe G, Kogler A, et al. Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus). J Neural Transm Gen Sect. 1993;93:71–74.
   PubMed Web of Science ®Google Scholar
• Ruottinen HM, Partinen M, Hublin C, et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology. 2000;54:502–504.
   PubMed Web of Science ®Google Scholar
• Michaud M, Soucy JP, Chabli A, Lavigne G, Montplaisir J. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol. 2002;249:164–170.
   PubMed Web of Science ®Google Scholar
• Garcia-Borreguero D, Larrosa O, Granizo JJ, de la Llave Y, Hening WA. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome. Sleep. 2004;27:669–673.
   PubMed Web of Science ®Google Scholar
• Ondo WG, He Y, Rajasekaran S, Le WD. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord. 2000;15:154–158.
   PubMed Web of Science ®Google Scholar
• Collado-Seidel V, Kohnen R, Samtleben W, et al. Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis. 1998;31:324–328.
   PubMed Web of Science ®Google Scholar
• Hui DS, Wong TY, Ko FW, et al. Prevalence of sleep disturbances in Chinese patients with end-stage renal failure on continuous ambulato- tory peritoneal dialysis. Am J Kidney Dis. 2000;36:783–788.
   PubMed Web of Science ®Google Scholar
• Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis. 1996;28:372–378.
   PubMed Web of Science ®Google Scholar
• Kurella B, Kraemer S, Winkler P. Restless legs syndrome and pregnancy. Results of a questionnaire-study. German Neurological Society; September 26–29, 2002; Göttingen, Germany.
   Google Scholar
• Lee KA, Zaffke ME, Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med. 2001;10:335–341.
   PubMedGoogle Scholar
• Ekbom KA. Restless legs: a clinical study. Acta Med Scand Suppl. 1945;158:1–122.
   Google Scholar
• Ekbom KA. Restless legs syndrome after partial gastrectomy. Acute Neurol Scand. 1966;42:79–89.
   Web of Science ®Google Scholar
• Banerji N, Hurwitz L. Restless legs syndrome, with particular reference to its occurrence after gastric surgery. Br Med J. 1970;4:774–775.
   PubMedGoogle Scholar
• Silber MH, Richardson JW. Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clin Proc. 2003;78:52–54.
   PubMed Web of Science ®Google Scholar
• Earley CJ, Heckler D, Allen RP. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med. 2004;5:231–235.
   PubMed Web of Science ®Google Scholar
• Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD. A doubleblind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis. 2004;43:663–670.
   PubMed Web of Science ®Google Scholar
• Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000;54:1698–1700.
   PubMed Web of Science ®Google Scholar
• Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med. 2004;5:385–391.
   PubMed Web of Science ®Google Scholar
• Allen RP, Barker PB, Wehrl F, et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56:263–265.
   PubMed Web of Science ®Google Scholar
• Boyer PJ, Ondo WG, Allen RP, et al. Neuropathologic evaluation of the central nervous system in restless legs syndrome: case report and review of literature. Soc Neurosci. 2000;2:2060.
   Google Scholar
• Erikson KM, Jones BC, Hess EJ, Zhang Q, Beard JL. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol Biochem Behav. 2001;69:409–418.
   PubMed Web of Science ®Google Scholar
• Allen RP, LaBuda MC, Becker P, Earley CJ. Family history study of the restless legs syndrome. Sleep Med. 2002;3:S3–S7.
   Web of Science ®Google Scholar
• Lazzarini A, Walters AS, Hickey K, et al. Studies of penetrance and anticipation in five autosomal-dominant restless legs syndrome pedigrees. Mov Disord. 1999;14:111–116.
   PubMed Web of Science ®Google Scholar
• Winkelmann J, Muller-Myhsok B, Wittchen HU, et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol. 2002;52:297–302.
   PubMed Web of Science ®Google Scholar
• Ondo WG, Vuong KD, Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology. 2000;55:1404–1406.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Seidel VC, Gasser T, Oertel WH. Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome. Mov Disord. 1996;11:389–394.
   PubMed Web of Science ®Google Scholar
• Desai AV, Cherkas LF, Spector TD, Williams AJ. Genetic influences in self-reported symptoms of obstructive sleep apnoea and legs: a twin study. Twin Res. 2004;7:589–595.
   Google Scholar
• Levchenko A, Montplaisir JY, Asselin G, et al. Autosomal dominant locus for restless legs syndrome in French-Canadians on chromosome 16p12.1. Mov Disord. 2009;24:40–50.
   PubMed Web of Science ®Google Scholar
• Lohmann-Hedrich K, Neumann A, Kleensang A, et al. Evidence for linkage of restless legs syndrome to chromosome 9p: are there two distinct loci? Neurology. 2008;70:686–694.
   Web of Science ®Google Scholar
• Pichler I, Hicks AA, Pramstaller PP. Restless legs syndrome: an update on genetics and future perspectives. Clin Genet. 2008;73:297–305.
   Web of Science ®Google Scholar
• Winkelmann J, Lichtner P, Schormair B, et al. Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome. Mov Disord. 2008;23:350–358.
   PubMed Web of Science ®Google Scholar
• Winkelmann J, Polo O, Provini F, et al. Genetics of restless legs syndrome (RLS): state-of-the-art and future directions. Mov Disord. 2007;22:S449–S458.
   PubMedGoogle Scholar
• Winkelmann J, Schormair B, Lichtner P et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39:1000–1006.
   PubMed Web of Science ®Google Scholar
• Young JE, Vilarino-Guell C, Lin SC, Wszolek ZK, Farrer M. Clinical and genetic description of a family with a high prevalence of autosomal dominant restless legs syndrome. Mayo Clin Proc. 2009;84:134–138.
   Web of Science ®Google Scholar
• Xiong L, Catoire H, Dion P, et al. MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA protein expression levels. Hum Mol Genet. 2009;18:1065–1074.
   Web of Science ®Google Scholar
• Stefansson H, Rye DB, Hicks A, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med. 2007;357:639–647.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Hening WA, Walters AS. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord. 1999;14:102–110.
   PubMed Web of Science ®Google Scholar
• Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12:61–66.
   PubMed Web of Science ®Google Scholar
• Montplaisir J, Boucher S, Nicolas A, et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Mov Disord. 1998;13:324–329.
   PubMed Web of Science ®Google Scholar
• Neikrug AB, Ancoli-Israel S. Sleep disorders in the older adult - a mini review. Gerontology. 2010;56:181–189.
   PubMed Web of Science ®Google Scholar
• Scofield H, Roth T, Drake C. Periodic limb movements during sleep: population prevalence, clinical correlates, and racial differences. Sleep. 2008;31:1221–1227.
   PubMed Web of Science ®Google Scholar
• Walters AS, Picchietti D, Hening W, Lazzarini A. Variable expressivity in familial restless legs syndrome. Arch Neurol. 1990;47:1219–1220.
   Google Scholar
• Walters AS, Picchietti DL, Ehrenberg BL, Wagner ML. Restless legs syndrome in childhood and adolescence. Pediatr Neurol. 1994;11:241–245.
   PubMed Web of Science ®Google Scholar
• Allen RP, Earley CJ. Defining the phenotype of the restless leg syndrome (RLS) using age-of-symptom-onset. Sleep Med. 2000;1:11–19.
   PubMed Web of Science ®Google Scholar
• Milligan SA, Chesson AL. Restless legs syndrome in the older adult: diagnosis and management. Drugs Aging. 2002;19:741–751.
   Web of Science ®Google Scholar
• Kushida CA. Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome. Am J Med. 2007;120:4–12.
   PubMed Web of Science ®Google Scholar
• Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord. 1995;10:634–642.
   PubMed Web of Science ®Google Scholar
• Nicolas A, Michaud M, Lavigne G, Montplaisir J. The influence of sex, age and sleep/wake state on characteristics of periodic leg movements in restless legs syndrome patients. Clin Neurophysiol. 1999;110: 1168–1174.
   Web of Science ®Google Scholar
• Michaud M, Lavigne G, Desautels A, Poirier G, Montplaisir J. Effects of immobility on sensory and motor symptoms of restless legs syndrome. Mov Disord. 2002;17:112–115.
   PubMed Web of Science ®Google Scholar
• Picchietti D, Allen RP, Walters AS, Davidson JE, Myers A, Ferini Strambi L. Restless legs syndrome: prevalence and impact in children and adolescents - the Peds REST Study. Pediatrics. 2007; 120:253–266.
   PubMed Web of Science ®Google Scholar
• Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101–119.
   Google Scholar
• Hornyak M, Kopasz M, Berger M, Riemann D, Voderholzer U. Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome. J Clin Psychiatry. 2005;66: 1139–1145.
   PubMed Web of Science ®Google Scholar
• Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep. 2005;28:891–898.
   PubMed Web of Science ®Google Scholar
• Pearson VE, Allen RP, Dean T, Gamaldo CE, Lesagne SR, Earley CJ. Cognitive deficits associated with restless legs syndrome (RLS). Sleep Med. 2006;7:25–30.
   PubMed Web of Science ®Google Scholar
• Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engï J Med. 2000;342:1378–1384.
   PubMed Web of Science ®Google Scholar
• Billars L, Hicks A, Bliwise D, et al. Hypertension risk and PLMS in restless legs syndrome. Sleep. 2007;30:A297–A298.
   Google Scholar
• Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep. 2009;32:589–597.
   PubMed Web of Science ®Google Scholar
• Silveira DC, Siddiqui F, Strus J, Fuentes K, Moussouttas M, Walters AS. Restless legs syndrome and cerebral microvascular ischemic disease. Neurology. 2007;68:A257.
   Web of Science ®Google Scholar
• Pennestri MH, Montplaisir J, Colombo R, Lavigne G, Lanfranchi PA. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology. 2007;68:1213–1218.
   PubMed Web of Science ®Google Scholar
• Winkelman JW. The evoked heart rate response to periodic leg movements of sleep. Sleep. 1999;22:575–580.
   PubMed Web of Science ®Google Scholar
• Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Associations of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology. 2008;70:35–42.
   PubMed Web of Science ®Google Scholar
• Aukerman MM, Aukerman D, Bayard M, et al. Exercise and restless legs syndrome: a randomized controlled trial. J Am BoardFam Med. 2006;19:487^93.
   Google Scholar
• Montplaisir J, Allen R, Walters A, Ferini-Strambi L. Restless legs syndrome and periodic limb movements during sleep. In: Roth T, Dement WC, editors. Principles and Practice of Sleep Medicine. 5th ed. Philadelphia: Elsevier; 2005.
   Google Scholar
• Hornyak M, Grossmann C, Kohnen R, et al. Cognitive behavioral group therapy to improve patients’ strategies for coping with restless legs syndrome: a proof-of-concept trial. J Neurol Neurosurg Psychiatry. 2008;79:823–825.
   PubMed Web of Science ®Google Scholar
• Von Scheele C, Kempi V, Long term effect of dopaminergic drugs in restless legs. A 2-year follow-up. Arch Neurol. 1990;47:1223–1224.
   PubMed Web of Science ®Google Scholar
• Early CJ, Allen RP. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep. 1996;19:801–810.
   PubMed Web of Science ®Google Scholar
• Garcia Borreguero D, Allen RP, Kohnen R, et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med. 2007;8:520–530.
   Web of Science ®Google Scholar
• Paulus W, Trenkwalder C. Less is more: pathophysiology of dopaminergic therapy related augmentation in restless legs syndrome. Lancet Neurol. 2006;5:878–886.
   PubMed Web of Science ®Google Scholar
• Allen R, Becker PM, Bogan R, et al. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep. 2004;27:907–914.
   PubMed Web of Science ®Google Scholar
• Bogan RK, Fry JM, Schmidt MH, Carson SW, Ritchie SY; TREAT RLS US Study Group. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized double-blind, placebocontrolled clinical trial. Mayo Clin Proc. 2006;81:17–27.
   PubMed Web of Science ®Google Scholar
• Montplaisir J, Nicolas A, Denesle R, Gomez Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology. 1999;52:938–940.
   PubMed Web of Science ®Google Scholar
• Partinen M, Hirvonen K, Jama L, et al. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study - the PRELUDE study. Sleep Med. 2006;7: 407–417.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Garcia Borreguero D, Montagna P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry. 2004;75:92–97.
   PubMed Web of Science ®Google Scholar
• Winkelman JW, Sethi KD, Kushida CA, et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology. 2006;67:1034–1039.
   PubMed Web of Science ®Google Scholar
• Montplaisir J, Fantini ML, Desautels A, Michaud M, Petit D, Filipini D. Long-term treatment with pramipexole in restless legs syndrome. Eur J Neurol. 2006;13:1306–1311.
   PubMed Web of Science ®Google Scholar
• Garcia Borreguero D, Grunstein R, Sridhar G, et al. A 52-week open- label study of the long-term safety of ropinirole in patients with restless legs syndrome. Sleep Med. 2007;8:742–752.
   Web of Science ®Google Scholar
• Manconi M, Ferri R, Zucconi M, et al. First night efficacy of pramipex- ole in restless legs syndrome and periodic legs movements. Sleep Med. 2007;8:491–497.
   PubMed Web of Science ®Google Scholar
• Quilici S, Abrams KR, Nicolas A, et al. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome. Sleep Med. 2008;9:715–726.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Benes H, Poewe W, et al. Efficacy of rotigotine for treatment of moderate to severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2008;7:595–604.
   PubMed Web of Science ®Google Scholar
• Happe S, Trenkwalder C. Role of dopamine receptor agonists in the treatment of restless legs syndrome. CNS Drugs. 2004;18: 27–36.
   PubMed Web of Science ®Google Scholar
• Bleumink GS, Van der Molen EM, Strijbos JH, Sanwikarja S, Van Puijenbroek EP, Stricker BH. Pergolide-induced pleuropulmonary fibrosis. Clin Neuropharmacol. 2002:25:290–293.
   Web of Science ®Google Scholar
• Danoff SK, Grasso ME, Terry PB, Flynn JA. Pleuropulmonary disease due to pergolide use for restless legs syndrome. Chest. 2001;120:313–316.
   PubMed Web of Science ®Google Scholar
• Horvath J, Fross RD, Kleiner Gisman G, et al. Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists. Mov Disord. 2004;19:656–662.
   PubMed Web of Science ®Google Scholar
• Baseman DG, O’ Suilleabhain PE, Reimold SC, Laskar SR, Baseman JG, Dewey RB Jr. Pergolide use in Parkinson disease is associated with cardiac valve regurgitation. Neurology. 2004;63:301–304.
   PubMed Web of Science ®Google Scholar
• Garcia Borreguero D, Larrosa O, De la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology. 2002;59:1573–1579.
   Web of Science ®Google Scholar
• Happe S, Sauter C, Klösch G, Saletu B, Zeitlhofer J. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology. 2003;48:82–86.
   PubMed Web of Science ®Google Scholar
• Oertel WH, Trenkwalder C, Zucconi M, et al. State of the art in restless legs syndrome: practice recommendations for treating restless legs syndrome. Mov Disord. 2007;22:S466–S475.
   Web of Science ®Google Scholar
• Trenkwalder C, Hening WA, Montagna P, et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord. 2008;23:2267–2302.
   PubMed Web of Science ®Google Scholar
• Walters AS, Winkelmann J, Trenkwalder C, et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord. 2001;16:1105–1109.
   PubMed Web of Science ®Google Scholar
• Walters AS, Wagner ML, Hening WA, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep. 1993;16:327–332.
   PubMed Web of Science ®Google Scholar
• Ondo WG. Methadone for refractory restless legs syndrome. Mov Disord. 2005;20:345–348.
   PubMed Web of Science ®Google Scholar
• Lauerma H, Markkula J. Treatment of restless legs syndrome with tramadol: an open study. J Clin Psychiatry. 1999;60:241–244.
   PubMed Web of Science ®Google Scholar
• Vetrugno R, La Morgia C, D’Angelo R, et al. Augmentation of restless legs syndrome with long-term tramadol treatment. Mov Disord. 2007;22:424–427.
   PubMed Web of Science ®Google Scholar
• Saletu M, Anderer P, Saletu-Zyhlarz G, et al. Restless legs syndrome (RLS) and periodic limb movements disorder (PLMD): acute placebocontrolled sleep laboratory studies with clonazepam. Eur Neurop- sychopharmacol. 2001;11:153–161.
   PubMed Web of Science ®Google Scholar
• Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep. 1999;22:970–999.
   PubMed Web of Science ®Google Scholar
• Huiqi Q, Shan L, Mingcai Q. Restless legs syndrome in uremic patients is related to the frequency of hemodialysis sessions. Nephron. 2000;86:540.
   PubMed Web of Science ®Google Scholar
• Collado-Seidel V, Kohnen R, Samtleben W, et al. Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis. 1998;31:324–328.
   PubMed Web of Science ®Google Scholar
• Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord. 2002;17:1072–1076.
   PubMed Web of Science ®Google Scholar
• Molnar MZ, Novak M, Ambrus C, et al. Restless legs syndrome in patients after renal transplantation. Am J Kidney Dis. 2005;45:388–396.
   PubMed Web of Science ®Google Scholar
• Manconi M, Govoni V, De Vito A, et al. Restless legs syndrome and pregnancy. Neurology. 2004;63:1065–1069.
   PubMed Web of Science ®Google Scholar
• Tunc T, Karadaq YS, Dogulu F, Inan LE. Predisposing factors of restless legs syndrome in pregnancy. Mov Disord. 2007;22:627–631.
   PubMed Web of Science ®Google Scholar
• Patrick LR. Restless legs syndrome: pathophysiology and the role of iron and folate. Altern Med Rev. 2007;12:101–112.
   PubMedGoogle Scholar
• Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med. 2006;7:545–552.
   PubMed Web of Science ®Google Scholar
• Sommer M, Bachmann CG, Liebetanz KM, et al. Pregabalin in restless legs syndrome with and without neuropathic pain. Acta Neurol Scand. 2007;115:347–350.
   PubMed Web of Science ®Google Scholar
• Guilleminault C, Palombini L, Pelayo R, Chervin RD. Sleepwalking and sleep terrors in prepubertal children: what triggers them? Pediatrics. 2003;111:e17–e25.
   PubMed Web of Science ®Google Scholar
• Konofal E, Arnulf I, Lecendreux M, Mouren MC. Ropinirole in a child with attention-deficit hyperactivity disorder and restless leg syndrome. Pediatr Neurol. 2005;32:350–351.
   PubMed Web of Science ®Google Scholar
• Walters AS, Mandelbaum DE, Lewin DS, Kugler S, England SJ, Miller M. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Study Group. Pediatr Neurol. 2000;22:182–186.
   PubMed Web of Science ®Google Scholar
• Picchietti MA, Picchietti DL. Restless legs syndrome and periodic limb movement disorder in children and adolescents. Semin Pediatr Neurol. 2008;15:91–99.
   PubMed Web of Science ®Google Scholar
• Simakajornboon N, Gozal D, Vlasic V, Mack C, Sharon D, McGinley B. Periodic limb movement in sleep and iron status in children. Sleep. 2003;26:735–738.
   PubMed Web of Science ®Google Scholar
• Konofal E, Lecendreux M, Arnulf I, Mouren MC. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2004;158:1113–1115.
   PubMedGoogle Scholar
• Pennestri M, Montplaisir J, Colombo R, et al. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology. 2007;68:1213–1218.
   PubMed Web of Science ®Google Scholar
• Earley CJ. Restless legs syndrome. N Engl J Med. 2003;348: 2103–2109.
   PubMed Web of Science ®Google Scholar
• Jankovic J. Post-traumatic movement disorders: central and peripheral mechanisms. Neurology. 1994;44:2008–2014.
   Web of Science ®Google Scholar
• Bhatt M, Desai J, Mankodi A, et al. Posttraumatic akinetic-rigid syndrome resembling. Parkinson’s disease: a report on three patients. Mov Disord. 2000;15:313–317.
   PubMed Web of Science ®Google Scholar
• Van Hilten JJ, Geraedts EJ, Marinus J. Peripheral trauma and movement disorders. Parkinsonism Relat Disord. 2007;13:S395–S399.
   Web of Science ®Google Scholar
• Krauss J, Jankovic J. Movement disorders after TBI. In: Zasler ND, Katz D, Zafonte R, editors. Brain Injury Medicine: Principles and Practice. New York: Demos; 2007:469–489.
   Google Scholar
• Rangarajan S, Rangarajan S, D’Souza GA. Restless legs syndrome in an Indian urban population. Sleep Med. 2007;9:88–93.
   PubMed Web of Science ®Google Scholar
• Gupta R, Lahan V, Goel D. Translation and validation of International Restless Leg Syndrome Study Group rating scale in Hindi language. Ann Indian Acad Neurol. 2011;14:257–261.
   Web of Science ®Google Scholar